Promino Nutritional Sciences Inc. Provides Corporate Update
Promino Nutritional Sciences (OTC:MUSLF) announced key updates regarding its product reformulation and regulatory challenges. The company has completed reformulating its Rejuvenate Muscle Health™ and Promino™ products with a new amino acid blend, eliminating the need for patent sublicense expenses.
EightIP LLC, the former patent sublicensor, has terminated their agreement and filed a claim in Nevada for unpaid royalty fees. Additionally, the company is working with auditors to file outstanding financial reports to address a cease trade order imposed on May 8, 2025 by the Ontario Securities Commission.
Promino Nutritional Sciences (OTC:MUSLF) ha annunciato aggiornamenti importanti riguardo alla riformulazione dei suoi prodotti e alle sfide regolatorie. L'azienda ha completato la riformulazione dei suoi prodotti Rejuvenate Muscle Health™ e Promino™ con una nuova miscela di amminoacidi, eliminando così la necessità di sostenere spese per sublicenze di brevetto.
EightIP LLC, l'ex sublicenziatario del brevetto, ha rescisso l'accordo e ha presentato un reclamo in Nevada per royalty non pagate. Inoltre, la società sta collaborando con i revisori contabili per presentare i rapporti finanziari mancanti, al fine di risolvere un ordine di cessazione delle negoziazioni imposto l'8 maggio 2025 dalla Ontario Securities Commission.
Promino Nutritional Sciences (OTC:MUSLF) anunció actualizaciones clave sobre la reformulación de sus productos y los desafíos regulatorios. La compañía ha completado la reformulación de sus productos Rejuvenate Muscle Health™ y Promino™ con una nueva mezcla de aminoácidos, eliminando la necesidad de gastos por sublicencias de patentes.
EightIP LLC, el antiguo sublicenciatario de la patente, ha terminado su acuerdo y presentó una demanda en Nevada por regalías impagas. Además, la empresa está trabajando con auditores para presentar los informes financieros pendientes y así atender una orden de cese de comercio impuesta el 8 de mayo de 2025 por la Comisión de Valores de Ontario.
Promino Nutritional Sciences (OTC:MUSLF)는 제품 재조정 및 규제 문제에 관한 주요 업데이트를 발표했습니다. 회사는 Rejuvenate Muscle Health™ 및 Promino™ 제품을 새로운 아미노산 혼합물로 재조정 완료하여 특허 서브라이선스 비용 부담을 없앴습니다.
이전 특허 서브라이선서인 EightIP LLC는 계약을 종료하고 네바다주에서 미지급 로열티에 대한 청구를 제기했습니다. 또한 회사는 온타리오 증권위원회가 2025년 5월 8일에 부과한 거래 중지 명령을 해결하기 위해 감사인과 협력하여 미제출 재무 보고서를 제출하고 있습니다.
Promino Nutritional Sciences (OTC:MUSLF) a annoncé des mises à jour importantes concernant la reformulation de ses produits et les défis réglementaires. La société a achevé la reformulation de ses produits Rejuvenate Muscle Health™ et Promino™ avec un nouveau mélange d'acides aminés, supprimant ainsi la nécessité de payer des frais de sous-licence de brevet.
EightIP LLC, l'ancien sous-licencié du brevet, a résilié leur accord et déposé une réclamation dans le Nevada pour des redevances impayées. De plus, la société collabore avec des auditeurs pour déposer les rapports financiers en suspens afin de répondre à un ordre de cessation de négociation imposé le 8 mai 2025 par la Commission des valeurs mobilières de l'Ontario.
Promino Nutritional Sciences (OTC:MUSLF) gab wichtige Neuigkeiten bezüglich der Produktneuformulierung und regulatorischer Herausforderungen bekannt. Das Unternehmen hat die Produkte Rejuvenate Muscle Health™ und Promino™ mit einer neuen Aminosäuremischung neu formuliert und dadurch die Notwendigkeit von Lizenzgebühren für Patentsublicenzen eliminiert.
EightIP LLC, der ehemalige Patentsublicenznehmer, hat die Vereinbarung beendet und in Nevada eine Klage wegen unbezahlter Lizenzgebühren eingereicht. Zusätzlich arbeitet das Unternehmen mit Wirtschaftsprüfern zusammen, um ausstehende Finanzberichte einzureichen und damit eine Handelsaussetzung, die am 8. Mai 2025 von der Ontario Securities Commission verhängt wurde, zu beheben.
- New product formulation eliminates future patent sublicense expenses
- Company reports product continues to deliver excellent results despite reformulation
- Legal claim filed by EightIP LLC for unpaid royalty fees
- Trading suspended due to cease trade order from Ontario Securities Commission
- Outstanding financial reports remain unfiled
Burlington, Ontario--(Newsfile Corp. - August 7, 2025) - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC Pink: MUSLF) (FSE: 93X) (the "Company" or "Promino") wishes to advise that it has completed a reformulation of its Rejuvenate Muscle Health™ and Promino™ products, which now rely on a new amino acid blend. The reformulated product no longer relies on the patented formulation previously employed by the Company, eliminating the need to incur future patent sublicense expenses, while still delivering excellent results for our customers.
EightIP LLC, the patent sublicensor in respect of the Company's legacy product formulation, has terminated the sublicense agreement in respect of the patent which was relied upon by the Company's legacy product formulation (see the Company's news release of December 6, 2023 for more information), and filed a claim in the state of Nevada for damages in respect of unpaid royalty fees and related remedies. On review of the claim, there are a number of defences available to the Company, and the Company is working to achieve an amicable settlement. Updates will be provided in due course.
The Company also advises that it is working diligently with its auditors to file outstanding financial reports in an effort to become eligible to have the ongoing cease trade order imposed on May 8, 2025 by the Ontario Securities Commission revoked so that it may resume trading on the Canadian Securities Exchange. Updates will similarly be provided in due course.
About Promino
Promino is an innovative and research driven Canadian nutraceutical company specializing in the development of science-based products for the global consumer packaged goods market, with a portfolio focused specifically on muscle health. Promino's lead product, Rejuvenate Muscle Health™ now benefits from a new formulation that aims to assist in the building, rebuilding, restoration and rejuvenation of natural muscle mass. Promino also offers Promino™, an elite performance supplement for both professional and amateur athletes to accelerate muscle recovery, build strength and accelerate recovery from injury. Promino was founded in 2015 and is located in Burlington, Ontario.
For more information about Rejuvenate Muscle™ Activator and where to purchase, visit www.rejuvenatemuscle.com.
To learn more about Promino, visit www.drinkpromino.com.
Forward-Looking Statements
This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. All statements that address activities, events, or developments that the Company expects or anticipates will, or may, occur in the future, are forward-looking statements, including statements regarding the Company's cease trade order, the status of ongoing litigation, continuous disclosure filings and business prospects. In some cases, forward-looking statements are preceded by, followed by, or include words such as "may", "will," "would", "could", "should", "believes", "estimates", "projects", "potential", "expects", "plans", "anticipates", "continues", or the negative of those words or other similar or comparable words. In preparing the forward-looking statements in this news release, the Company has applied several material assumptions, including, but not limited to prompt completion of the FY 2024 audit, and that general business and economic conditions will not change in a materially adverse manner. These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance or achievements expressed or implied by such forward-looking statements. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors.
No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.
For further information about Promino:
Vito Sanzone, CEO, vsanzone@drinkpromino.com, 289-348-1970 ext. 222
Marc Charbin, Investor Relations, marc.charbin@loderockadvisors.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/261618
FAQ
What changes did Promino Nutritional Sciences (MUSLF) make to its products in 2025?
Why is Promino Nutritional Sciences stock not trading on the Canadian Securities Exchange?
What legal challenges is Promino Nutritional Sciences (MUSLF) facing in 2025?
How is Promino Nutritional Sciences addressing its cease trade order?
